-
Perospirone (SM-9018 Freebase): New Insights into Ion Channe
2026-05-31
Explore the advanced pharmacology of Perospirone (SM-9018 freebase), emphasizing its unique effects on voltage-gated K+ channels beyond classic receptor antagonism. This article delivers a deeper analysis of its mechanistic and cross-domain research value for schizophrenia and cardiovascular studies.
-
A 83-01: ALK-5 Inhibitor Workflows for Organoid & EMT Resear
2026-05-30
A 83-01 (ALK inhibitor) empowers researchers to precisely modulate TGF-β signaling in organoid, EMT, and stem cell studies. Discover stepwise protocols, troubleshooting strategies, and the latest innovations that make this ALK-5 inhibitor a cornerstone for high-fidelity, reproducible cellular assays.
-
IL-18 Tetrapeptide Tools Reveal Shared Caspase Specificity
2026-05-29
This study introduces peptide-based probes derived from the IL-18 tetrapeptide sequence to dissect substrate specificity across inflammatory and apoptotic caspases. Findings reveal unexpected overlap in specificity between caspase-1 and caspase-8, with implications for the use and interpretation of selective caspase inhibitors in cell death and inflammation research.
-
Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo
2026-05-29
Vacuolin-1 enables selective, reproducible blockade of lysosomal exocytosis, advancing both mechanistic studies and translational assays in membrane trafficking research. Here, we bridge the latest cartilage pathology findings with hands-on workflow enhancements and troubleshooting guidance for optimal lab performance.
-
Staurosporine: Broad-Spectrum Kinase Inhibitor in Cancer Wor
2026-05-28
Staurosporine is the benchmark broad-spectrum serine/threonine protein kinase inhibitor for apoptosis induction and kinase pathway dissection in cancer research. APExBIO’s Staurosporine empowers researchers with reproducible, high-sensitivity workflows, from cytotoxicity profiling to advanced anti-angiogenic studies.
-
Artemisinin Blocks Ferroptosis via NRF2 Activation in Diabet
2026-05-28
Wang et al. demonstrate that artemisinin reverses cognitive decline in a type 2 diabetes mouse model by activating NRF2 and suppressing ferroptosis in hippocampal neurons. Their work clarifies the mechanistic link between oxidative stress, NRF2 signaling, and neuroprotection, offering new directions for mitigating diabetes-associated cognitive impairment.
-
7-Ethyl-10-hydroxycamptothecin: Advanced Colon Cancer Assays
2026-05-27
7-Ethyl-10-hydroxycamptothecin (SN-38) delivers precise, dual-pathway modulation for advanced colon cancer research, combining potent topoisomerase I inhibition with FUBP1 pathway disruption. This guide translates the latest reference findings into actionable workflows, troubleshooting advice, and protocol enhancements for reproducible, high-impact results.
-
Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo
2026-05-27
Vacuolin-1 empowers researchers to dissect lysosome-driven membrane repair and signaling with unmatched specificity. This guide translates bench research into actionable protocols and troubleshooting strategies for advanced lysosomal exocytosis inhibition in cell biology and disease modeling.
-
Gut-Brain Cholinergic Circuits in B. fragilis-Mediated Seizu
2026-05-26
Jia et al. demonstrate that Bacteroides fragilis suppresses seizures through vagus-mediated gut-brain cholinergic signaling, linking microbiota composition directly to neural circuit modulation. Their integrative approach, spanning mouse models and clinical validation, offers mechanistic insight for microbiota-targeted interventions in pediatric refractory epilepsy.
-
Calpain Inhibitor I, ALLN: Technical Guidance for Research U
2026-05-26
Calpain Inhibitor I, ALLN is a potent, selective inhibitor for calpain and cathepsin proteases, supporting precise modulation in apoptosis assays and ischemia-reperfusion injury models. It is unsuitable for diagnostic, therapeutic, or water-based workflows due to solubility and regulatory constraints. Researchers should follow best practices for solubilization, storage, and assay integration to maintain reproducibility.
-
Translating 6-thioguanine: Mechanisms and Strategic Impact
2026-05-25
This thought-leadership article delivers a mechanistic and strategic roadmap for translational researchers leveraging 6-thioguanine in cancer and viral disease models. Integrating recent findings on EV71 virus inhibition, this piece explores how DNA methyltransferase 1 (DNMT1) inhibition and autophagy modulation underpin the dual antitumor and antiviral profile of thioguanine. APExBIO’s high-purity compound is highlighted for protocol reliability, while workflow guidance and limitations are clearly outlined for advancing next-generation therapeutics.
-
Structure-Based Screening Reveals NSP15 Inhibitors for SARS-
2026-05-25
This study pioneers structure-based virtual screening to identify thymopentin and oleuropein as potent inhibitors of the NSP15 endoribonuclease in SARS-CoV-2. The findings highlight new molecular strategies for impeding viral immune evasion, offering a foundation for future antiviral development.
-
Rosemary Extract Inhibits Renal Amyloidosis via ER Stress an
2026-05-24
This study demonstrates the anti-renal amyloidosis potential of rosemary extract, revealing its ability to disrupt amyloid fibril aggregation, restore cellular homeostasis, and mitigate apoptosis in both in vitro and in vivo models. The multidimensional mechanistic approach provides novel insights into programmed cell death pathways in kidney disease and highlights the value of precise apoptosis detection tools for translational research.
-
Piezo2 and CGRP/SP in Trigeminal Neuralgia: Neuroinflammatio
2026-05-23
Liao et al. reveal that chronic trigeminal nerve root compression induces a neuroinflammatory response, driving mechanical allodynia via a Ca2+-CGRP/SP-Piezo2 positive feedback loop. This study establishes new mechanistic links between ATP-driven intracellular signaling, neuropeptide expression, and mechanosensory hypersensitivity, offering refined targets for neuropathic pain intervention.
-
Technical Use of Angiotensin I/II (1-5) in RAS Research
2026-05-22
Angiotensin I/II (1-5) addresses the need for a precisely defined Asp-Arg-Val-Tyr-Ile peptide fragment in renin-angiotensin system (RAS) research, particularly for modeling blood pressure regulation and aldosterone release. It is suitable for cardiovascular and renal workflows but should not be used in unrelated peptide signaling studies due to its specific solubility and mechanistic profile.